Lyra Therapeutics LYRA
LYRA
$0.20 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Lyra Therapeutics (LYRA) Restructuring Costs (2024 - 2025)

Updated

Lyra Therapeutics (LYRA) posted Restructuring Costs of $200,000 for Q4 2025, down 87.8% from $1.65 million a year earlier.

Analysis

Lyra Therapeutics (LYRA) Restructuring Costs (2024 - 2025) Analysis & Trends

For FY2025, Lyra Therapeutics' Restructuring Costs came in at $1.5 million, down 86.2% from FY2024.

  • In prior years, Lyra Therapeutics' Restructuring Costs was $10.9 million in FY2024.
  • Quarterly Restructuring Costs has run from a low of -$21,000 in Q3 2025 to a high of $6.45 million in Q2 2024 over five years.
  • According to Business Quant data, Restructuring Costs for the three prior quarters was -$21,000 (Q3 2025), $400,000 (Q2 2025) and $900,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Lyra Therapeutics 354,976.41 354,976.41 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 200,000.00
Sep 30, 2025 -21,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 900,000.00
Dec 31, 2024 1.65 Mn
Sep 30, 2024 2.80 Mn
Jun 30, 2024 6.45 Mn
API Access

Lyra Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=LYRA&period=max&api_key=YOUR_API_KEY